The Viral Hepatitis Epidemiology and Prevention Program strives to conduct multidisciplinary public health research that is ethical, innovative and makes a difference. We are proud of, and committed to, working in partnership with affected communities in Australia and internationally to achieve our goals. Key aims of the program are to:

• Initiate and undertake epidemiological, social and behavioural research examining viral hepatitis and public health issues associated with drug use and risk behaviour;
• Design and implement trials of behavioural and biomedical prevention interventions designed to prevent viral hepatitis and other infectious diseases in vulnerable populations;
• Conduct and support surveillance activities including monitoring trends in blood-borne virus incidence, prevalence and risk behaviour among people who inject drugs;
• Translate research outcomes into evidence-based public health practice; and
• Build capacity for research, surveillance and harm reduction within Australia and the region through the provision of training and technical assistance.